THE MANAGEMENT OF CYTOTOXIC-DRUG EXTRAVASATION - GUIDELINES DRAWN UP BY A WORKING PARTY FOR THE CLINICAL ONCOLOGICAL SOCIETY OF AUSTRALIA

被引：22

作者：

COX, K ^{[1
]}

STUARTHARRIS, R ^{[1
]}

ABDINI, G ^{[1
]}

GRYGIEL, J ^{[1
]}

RAGHAVAN, D ^{[1
]}

机构：

[1] UNIV SYDNEY,LUDWIG INST CANC RES,SYDNEY,NSW 2006,AUSTRALIA

来源：

MEDICAL JOURNAL OF AUSTRALIA | 1988年 / 148卷 / 04期

关键词：

D O I：

10.5694/j.1326-5377.1988.tb112811.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：185 / 189

页数：5

共 42 条

[1]

ALGARRA SM, 1986, CANCER TREAT REP, V70, P687

[2] NURSING MANAGEMENT OF ADRIAMYCIN EXTRAVASATION [J].

BARLOCK, AL ;

HOWSER, DM ;

HUBBARD, SM .

AMERICAN JOURNAL OF NURSING, 1979, 79 (01) :94-96

[3] SOFT-TISSUE NECROSIS INDUCED BY EXTRAVASATED CANCER CHEMOTHERAPEUTIC-AGENTS - A STUDY OF ACTIVE INTERVENTION [J].

BARR, RD ;

SERTIC, J .

BRITISH JOURNAL OF CANCER, 1981, 44 (02) :267-269

[4]

BARTKOWSKIDODDS L, 1980, CANCER CHEMOTH PHARM, V4, P179

[5]

BLAIR WF, 1980, CLIN ORTHOP RELAT R, V151, P228

[6] ADRIAMYCIN EXTRAVASATION [J].

BOWERS, DG ;

LYNCH, JB .

PLASTIC AND RECONSTRUCTIVE SURGERY, 1978, 61 (01) :86-92

[7]

CHAIT LA, 1975, S AFR MED J, V49, P1935

[8]

COHEN MH, 1979, CANCER TREAT REP, V63, P1003

[9]

DESAI MH, 1982, CANCER TREAT REP, V66, P1371

[10]

DONAGIN WG, 1982, SEMIN ONCOL, V9, P14

← 1 2 3 4 5 →